Cargando…
Engineering eukaryotic protein factories
The biopharmaceuticals market is currently outperforming the pharmaceuticals market and is now valued at US$ 48 billion with an average annual growth of 19%. Behind this success is a 100-fold increase in productivities of eukaryotic expression systems. However, the productivity per cell has remained...
Autor principal: | Schröder, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151841/ https://www.ncbi.nlm.nih.gov/pubmed/17885737 http://dx.doi.org/10.1007/s10529-007-9524-1 |
Ejemplares similares
-
Recombinant production of eukaryotic cytochrome P450s in microbial cell factories
por: Hausjell, Johanna, et al.
Publicado: (2018) -
Metabolic engineering of microbial cell factories for production of nutraceuticals
por: Yuan, Shuo-Fu, et al.
Publicado: (2019) -
Systems biology and metabolic engineering of Arthrospira cell factories
por: Klanchui, Amornpan, et al.
Publicado: (2012) -
The Factory System and Factory Statistics
Publicado: (1837) -
Microbial Consortia Engineering for Cellular Factories: in vitro to in silico systems
por: Bernstein, Hans C, et al.
Publicado: (2012)